Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
515074
Reference Type
Journal Article
Title
Hyperprolactinemia and galactorrhea associated with marijuana use
Author(s)
Rizvi, AA
Year
2006
Is Peer Reviewed?
Yes
Journal
Endocrinologist
ISSN:
1051-2144
Volume
16
Issue
6
Page Numbers
308-310
Language
English
DOI
10.1097/01.ten.0000250184.10041.9d
Abstract
A 23-year-old woman presented with breast tenderness and bilateral nipple discharge. She was found to have a prolactin level of 136.9 ng/mL, negative serum pregnancy test, normal pituitary anatomy on imaging, and no other discernible cause for the hyperprolactinemia. Bromocriptine treatment normalized the prolactin and considerably reduced the galactorrhea. After 3 months of therapy, the patient revealed that she had been a heavy weekend marijuana user for more than 1 year but had stopped completely recently. Bromocriptine was discontinued while the patient abstained from further marijuana smoking. One month later, the prolactin level was normal and no breast abnormalities or nipple discharge was evident. In conclusion, periodic, heavy, and regular marijuana use can cause clinically significant hyperprolactinemia over the long term that can present a diagnostic dilemma and lead to unnecessary medical therapy. It should be considered as a reversible cause of elevated prolactin and should be kept in mind in the differential diagnosis of galactorrhea in women.
Keywords
marijuana; hyperprolactinemia; galactorrhea; pituitary; hypothalamus; follicle-stimulating-hormone; prolactin levels; luteinizing-hormone; human males; smoking; testosterone; women
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity